Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.050
+0.021 (0.69%)
May 26, 2026, 2:26 PM EDT - Market open
Xenetic Biosciences Employees
Xenetic Biosciences had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,595,037
Profits / Employee
-$1,117,051
Market Cap
6.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | -2 | -50.00% | 2 | 0 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2021 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| BiomX | 20 |
| Processa Pharmaceuticals | 12 |
| Purple Biotech | 10 |
| Immuron | 7 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
| Silo Pharma | 3 |
XBIO News
- 8 days ago - Xenetic Biosciences Slides: Investor presentation - Filings
- 13 days ago - Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform - Accesswire
- 14 days ago - Xenetic Biosciences Quarterly report: Q1 2026 - Filings
- 14 days ago - Xenetic Biosciences Earnings release: Q1 2026 - Filings
- 4 weeks ago - Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting - Accesswire
- 5 weeks ago - Xenetic Biosciences Slides: Corporate presentation - Filings
- 2 months ago - Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results - Accesswire
- 2 months ago - Xenetic Biosciences Earnings release: Q4 2025 - Filings